15618 Federal Register / Vol. 80, No. 56 / Tuesday, March 24, 2015 / Notices 

Effectiveness against LaboratoryConfirmed Influenza-Associated 

Hospitalizations, FOA IP15–002, initial 

review. 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting: 

Time And Date: 10:00 a.m.–4:00 p.m., 

April 15, 2015 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to 

the public in accordance with 

provisions set forth in Section 

552b(c)(4) and (6), Title 5 U.S.C., and 

the Determination of the Director, 

Management Analysis and Services 

Office, CDC, pursuant to Public Law 92– 

463. 

Matters For Discussion: The meeting 

will include the initial review, 

discussion, and evaluation of 

applications received in response to 

‘‘Economic Studies of Immunization 

Policies and Practices’’, FOA IP15–001 

and ‘‘US Platform to Measure Influenza 

Vaccine Effectiveness against 

Laboratory-confirmed Influenzaassociated Hospitalizations’’, FOA IP15– 

002. 

Contact Person For More Information: 

Gregory Anderson, M.S., M.P.H., 

Scientific Review Officer, CDC, 1600 

Clifton Road NE., Mailstop E60, Atlanta, 

Georgia 30333, Telephone: (404) 718– 

8833. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2015–06651 Filed 3–23–15; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Initial Review 

The meeting announced below 

concerns Detection and Characterization 

of Emerging Vector-Borne Zoonotic 

Pathogens in Indonesia, CK15–001; 

Sentinel Enhanced Dengue Surveillance 

System (SEDSS) Sites to Evaluate the 

Epidemiology and Prevention of Dengue 

and other Acute Febrile Illnesses in 

Puerto Rico, CK15–002, and Capacity 

Building to Prevent, Detect, and 

Respond to Emerging Infectious Disease 

Threats and Strengthen Global Health 

Security in Uganda, CK15–003, Funding 

Opportunity Announcement (FOA), 

initial review. 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting: 

Time And Date: 11:00 a.m.–3:00 p.m., 

April 21, 2015 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to 

the public in accordance with 

provisions set forth in Section 552b(c) 

(4) and (6), Title 5 U.S.C., and the 

Determination of the Director, 

Management Analysis and Services 

Office, CDC, pursuant to Public Law 92– 

463. 

Matters For Discussion: The meeting 

will include the initial review, 

discussion, and evaluation of 

applications received in response to 

‘‘Detection and Characterization of 

Emerging Vector-Borne Zoonotic 

Pathogens in Indonesia’’, FOA CK15– 

001 and ‘‘Sentinel Enhanced Dengue 

Surveillance System (SEDSS) Sites to 

Evaluate the Epidemiology and 

Prevention of Dengue and other Acute 

Febrile Illnesses in Puerto Rico’’, FOA 

CK15–002, and ‘‘Capacity Building to 

Prevent, Detect, and Respond to 

Emerging Infectious Disease Threats and 

Strengthen Global Health Security in 

Uganda’’, FOA CK15–003. 

Contact Person For More Information: 

Gregory Anderson, M.S., M.P.H., 

Scientific Review Officer, CDC, 1600 

Clifton Road NE., Mailstop E60, Atlanta, 

Georgia 30333, Telephone: (404) 718– 

8833 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2015–06652 Filed 3–23–15; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–15–15GD] 

Proposed Data Collections Submitted 

for Public Comment and 

Recommendations 

The Centers for Disease Control and 

Prevention (CDC) has submitted the 

following information collection request 

to the Office of Management and Budget 

(OMB) for review and approval in 

accordance with the Paperwork 

Reduction Act of 1995. The notice for 

the proposed information collection is 

published to obtain comments from the 

public and affected agencies. 

Written comments and suggestions 

from the public and affected agencies 

concerning the proposed collection of 

information are encouraged. Your 

comments should address any of the 

following: (a) Evaluate whether the 

proposed collection of information is 

necessary for the proper performance of 

the functions of the agency, including 

whether the information will have 

practical utility; (b) Evaluate the 

accuracy of the agencies estimate of the 

burden of the proposed collection of 

information, including the validity of 

the methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; (d) Minimize the burden of 

the collection of information on those 

who are to respond, including through 

the use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and (e) Assess information 

collection costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570 or 

send an email to omb@cdc.gov. Written 

comments and/or suggestions regarding 

the items contained in this notice 

should be directed to the Attention: 

CDC Desk Officer, Office of Management 

and Budget, Washington, DC 20503 or 

by fax to (202) 395–5806. Written 

comments should be received within 30 

days of this notice. 

Proposed Project 

Emergency Self Escape for Coal 

Miners—New—National Institute for 

Occupational Safety and Health 

(NIOSH), Centers for Disease Control 

and Prevention (CDC). 

mstockstill on DSK4VPTVN1PROD with NOTICES